Skip Ribbon Commands Skip to main content

Making products better together

With over 25 years in the biopharmaceutical industry, Novozymes Biopharma is dedicated to providing specialized technology solutions and recombinant products such as recombinant albumin and hyaluronic acid, tailored to the needs of the drug delivery and medical device industries. Our customer-integrated approach combines Novozymes Biopharma’s scientific know-how with the specific needs of customers to deliver improved products and performance.
Recombinant albumin and hyaluronic acid are produced in large-scale manufacturing facilities worldwide, which are operated to Q7 cGMP quality standards to ensure the highest level of product quality, consistency, and security of long-term supply.
Our customer focused partnering approach packages our award winning technologies such as half-life extension with over 25 years of scientific, technical and regulatory support to customers for the delivery of improved and better performing products.




May19, 2015
> Novozymes Biopharma enables stable formulation of Serendex Pharmaceutical’s inhalable biological drug for treatment of severe pulmonary diseases. Read more

Dec 22, 2014
> Novozymes Biopharma enters license agreement with EpiVax to advance pioneering treatment of autoimmune diseases. Read more

Dec 11, 2014
> Expert Opinion on Drug Delivery publishes peer reviewed article on the application of albumin for drug delivery. Read more


› To view upcoming events click here

Copyright © 2015 Novozymes. All rights reserved.